Skip to main navigation Skip to search Skip to main content

Monthly: Fate Therapeutics (FATE: $3.50) falls a second month, trailing 86% of stocks

Press/Media

Period1 Oct 2024

Media coverage

1

Media coverage

  • TitleMonthly: Fate Therapeutics (FATE: $3.50) falls a second month, trailing 86% of stocks
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date1/10/24
    PersonsJared Scott
View all 1
View less